Can COX-2 Inhibitor Decrease Stricture Recurrence After Direct Vision Internal Urethrotomy?
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
To evaluate the efficacy and safety of nonsteroidal anti-inflammatory drugs (NSAIDs) in preventing urethral stricture recurrence after direct visual internal urethrotomy.
Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥ 18 years
• American Society of Anesthesiologists (ASA) score ≤3.
• Urethral stricture length ≤ 1.5 cm
Locations
Other Locations
Egypt
New Valley University
RECRUITING
New Valley
Contact Information
Primary
Waheed F Abdelrasol, MD
waheed_fawzy@med.nvu.edu.eg
00201207722518
Time Frame
Start Date: 2024-11-20
Estimated Completion Date: 2025-04-01
Participants
Target number of participants: 82
Treatments
Experimental: Nonsteroidal anti-inflammatory drugs
Patients will undergo direct vision internal urethrotomy (DVIU) plus nonsteroidal anti-inflammatory drugs (NSAID) for 3 weeks.
Placebo_comparator: Control group
Patients will undergo direct vision internal urethrotomy (DVIU) plus a placebo for 3 weeks.
Related Therapeutic Areas
Sponsors
Leads: New Valley University